Oligometastatic Prostate Cancer Clinical Trials
0 recruiting
Showing 1–7 of 7 trials
Recruiting
Not Applicable
5500/20 vs. SABR or Brachytherapy for PRimary OligoMetastatic Prostate Cancer Treatment (PROMPT)
Oligometastatic Prostate Cancer
British Columbia Cancer Agency168 enrolled4 locationsNCT04610372
Recruiting
Not Applicable
Comprehensive Versus Primary Tumor Radiotherapy in Oligometastatic Prostate Cancer
Prostate CancerOligometastatic Prostate Cancer
Peking University First Hospital390 enrolled3 locationsNCT07015138
Recruiting
Phase 2
Lu-PSMA for Oligometastatic Prostate Cancer Treated With STereotactic Ablative Radiotherapy
Oligometastatic Prostate Cancer
Peter MacCallum Cancer Centre, Australia92 enrolled3 locationsNCT05560659
Recruiting
Phase 2
Adenosine Signaling Modulation and Immune Checkpoint Inhibition With Hormone Sensitive Oligometastatic Prostate Cancer
Oligometastatic Prostate Cancer
Catherine Spina23 enrolled1 locationNCT05915442
Recruiting
Phase 2Phase 3
Maximal Tumor Eradication for Oligometastatic Prostate Cancer
Oligometastatic Prostate Cancer
RenJi Hospital120 enrolled1 locationNCT06972511
Recruiting
Phase 2
Genomic Biomarker-guided Neoadjuvant Therapy for Prostate Cancer (SEGNO)
Locally Advanced Prostate CancerOligometastatic Prostate Cancer
The First Affiliated Hospital of Xiamen University40 enrolled1 locationNCT06387056
Recruiting
Prostate Oligometastatic Cancer Management Driven by Disease Biology et/or Immunoactivity (PROMETEO)
Oligometastatic Prostate Cancer
Centro di Riferimento Oncologico - Aviano104 enrolled2 locationsNCT06060652